Journal of the American Society of Hypertension
Volume 3, Issue 3 , Pages 221-227 , May 2009

Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice

  • Isabelle Mulazzi, MD

      Affiliations

    • Département de Médecine Générale, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    • ,
  • Jean Pierre Cambou, MD

      Affiliations

    • INSERM 558, Toulouse, France
    • ,
  • Xavier Girerd, MD

      Affiliations

    • Hôpital Pitié Salpêtrière, Paris, France
    • ,
  • Robert Nicodeme, MD

      Affiliations

    • Département de Médecine Générale, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    • ,
  • Bernard Chamontin, MD

      Affiliations

    • INSERM 558, Toulouse, France
    • Service de Médecine Interne et d'Hypertension Artérielle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    • ,
  • Jacques Amar, MD

      Affiliations

    • INSERM 558, Toulouse, France
    • Service de Médecine Interne et d'Hypertension Artérielle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    • Corresponding Author InformationCorresponding author: Jacques Amar, MD, Centre Hospitalier Universitaire de Toulouse, Hopital Rangueil, Department of Internal Medicine and Arterial Hypertension, Toulouse, France. Tel: +33 5 61 323 084; fax: +33 5 61 32 27 10.

Received 22 August 2008 ,Accepted 13 December 2008.

References 

  1. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011–53.
  2. Shankar A, Wang JJ, Rochtchina E, Mitchell P. Positive association between plasma fibrinogen level and incident hypertension among men. Population-based cohort study. Hypertension. 2006;48:1043–1049
  3. Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B. PRATIK Study Investigators. Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK Study). J Hypertens. 2002;20:779–784
  4. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention?. J Hypertens. 2003;21:1199–1205
  5. Amar J, Chamontin B, Ferrieres J, Danchin N, Grenier O, Cantet C, et al. Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis—the PREVENIR Study. Heart. 2002;88:587–591
  6. Amar J, Cambou JP, Quentzel S, Amelineau E, Danchin N. Controlled diastolic blood pressure, previous stroke and associated risk factors are obstacles to improving systolic blood pressure. J Hum Hypertens. Forthcoming.
  7. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554–572
  8. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–37
  9. Setaro JF, Black HR. Refractory hypertension. N Engl J Med. 1992;327:543–546
  10. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med. 1991;151:1786–1792
  11. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811
  12. Stewart M. The validity of an interview to assess a patient's drug taking. Am J Prev Med. 1987;3:95–100
  13. Kruse W, Weber E. Dynamics of drug regimen compliance. Its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 1990;38:561–565
  14. Mallion JM, Meilhac B, Tremel F, Calvez R, Bertholom N. Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol. 1992;19:S41–S48
  15. Vaur L, Vaisse B, Genes N, Elrik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance. Results of a large-scale trial. Am J Hypertens. 1999;12:374–380
  16. Waeber B, Burnier M, Brunner HR. Compliance with antihypertensive therapy. Clin Exp Hypertens. 1999;21:973–985
  17. Girerd X, Radauceanu A, Achard JM, Fourcade J, Tournier B, Brillet G, et al. The compliance evaluation test: a validated tool for detection of nonadherence among hypertensive treated patients. Arch Mal Cœur. 2001;94:839–842
  18. Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Presse Med. 2001;30:1044–1048
  19. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19:1190–1196
  20. Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl. 2003;21:S37–S42
  21. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001;19:335–341
  22. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74
  23. Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. Alcohol consumption and the incidence of hypertension: the Atherosclerosis Risk in Communities Study. Hypertension. 2001;37:1242–1250
  24. MacMahon SW, Blacket RB, Macdonald GJ, Hall W. Obesity, alcohol consumption and blood pressure in Australian men and women: the National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens. 1984;2:85–91
  25. Marques-Vidal P, Arveiler D, Evans A, Amouyel P, Ferrieres J, Ducimetiere P. Different alcohol drinking and blood pressure relationships in France and Northern Ireland: the PRIME Study. Hypertension. 2001;38:1361–1366
  26. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000;18:679–685
  27. Schrier RW. Treating high-risk diabetic hypertensive patients with comorbid conditions. Am J Kidney Dis. 2000;36:S10–S17
  28. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–315
  29. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens. 2001;19:381–387
  30. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117

 The ESPERE Study and the analysis of these data were financially supported by Sanofi Aventis. Dr. Amar received consultancy fees from Sanofi Aventis to design and analyze the study.

 Conflict of interest: none.

PII: S1933-1711(08)00235-0

doi: 10.1016/j.jash.2008.12.004

Journal of the American Society of Hypertension
Volume 3, Issue 3 , Pages 221-227 , May 2009

Article Tools

* Image Usage & Resolution